4//SEC Filing
Cohen Neil Harris 4
Accession 0001178913-22-001022
CIK 0001534248other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:05 PM ET
Size
9.6 KB
Accession
0001178913-22-001022
Insider Transaction Report
Form 4
Cohen Neil Harris
Directorinterim CEO
Transactions
- Award
Option to Purchase American Depositary Shares
2022-03-07+6,820→ 6,820 totalExercise: $3.53Exp: 2032-03-07→ American Depositary Shares (6,820 underlying)
Holdings
- 11,884
Option to Purchase American Depositary Shares
Exercise: $27.26Exp: 2031-04-19→ American Depositary Shares (11,884 underlying) - 688
Option to Purchase American Depositary Shares
Exercise: $13.17Exp: 2030-03-15→ American Depositary Shares (688 underlying) - 4,409
American Depositary Shares
Footnotes (5)
- [F1]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F2]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F3]These options vest and become exercisable in their entirety on March 16, 2023.
- [F4]These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
- [F5]These options vest and become exercisable as follows: 1/3 vest on July 16, 2021, and the remaining options vest on a quarterly basis for the following eight quarters, subject to the Reporting Person's continued service.
Documents
Issuer
Chemomab Therapeutics Ltd.
CIK 0001534248
Entity typeother
Related Parties
1- filerCIK 0001840006
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 4:05 PM ET
- Size
- 9.6 KB